Voloridge Investment Management, LLC Sage Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q2 2024

A detailed history of Voloridge Investment Management, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 429,837 shares of SAGE stock, worth $3.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

429,837

Previous 552,641 22.22%

Holding current value

$3.1 Million

Previous $10.4 Million 54.92%

% of portfolio

0.02%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.58 - $17.9 $1.3 Million - $2.2 Million	-122,804 Reduced 22.22%	429,837 $4.67 Million
Q1 2024 May 15, 2024	BUY	$18.62 - $26.95 $2.98 Million - $4.31 Million	159,942 Added 40.73%	552,641 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $5.5 Million - $7.16 Million	321,731 Added 453.35%	392,699 $8.51 Million
Q3 2023 Nov 14, 2023	BUY	$16.75 - $48.98 $1.19 Million - $3.48 Million	70,968 New	70,968 $1.46 Million
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $2.41 Million - $3.33 Million	87,661 Added 197.26%	132,101 $4.27 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $2.76 Million - $4.1 Million	-89,805 Reduced 66.9%	44,440 $1.47 Million
Q4 2021 Feb 14, 2022	SELL	$37.06 - $47.11 $3.93 Million - $4.99 Million	-105,962 Reduced 44.11%	134,245 $5.71 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $3.77 Million - $5.37 Million	93,661 Added 63.91%	240,207 $10.6 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $1.13 Million - $1.63 Million	-20,513 Reduced 12.28%	146,546 $8.33 Million
Q1 2021 May 17, 2021	SELL	$70.65 - $96.76 $539,766 - $739,246	-7,640 Reduced 4.37%	167,059 $12.5 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $552,091 - $841,795	9,452 Added 5.72%	174,699 $15.1 Million
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $7.49 Million - $11.4 Million	-182,106 Reduced 52.43%	165,247 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $3.73 Million - $6.2 Million	143,641 Added 70.51%	347,353 $14.4 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $4.89 Million - $14.5 Million	187,161 Added 1130.81%	203,712 $5.85 Million
Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $58,555 - $150,591	-973 Reduced 5.55%	16,551 $1.2 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $2.46 Million - $3.33 Million	17,524 New	17,524 $2.46 Million
Q1 2018 May 15, 2018	SELL	$152.15 - $192.33 $8.2 Million - $10.4 Million	-53,908 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $3.27 Million - $9.02 Million	53,908	53,908 $8.88 Million

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

48.2M

Call Options Held

854K

Put Options Held

195K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $428M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Sage Therapeutics, Inc. Transaction History